Elevation Oncology

Developer of precision medicine for the treatment of cancer

placeNew York City, New York, United States calendar_todayFounded 2019 groups29 employees language elevationoncology.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 70 times.

YearFilings
20222
20242

Investor mix

15 investors on record; lead investors include Aisling Capital, VenBio, Cormorant Capital, Array; 4 have since exited.

Investor typeCountShare
Venture capital747%
Private equity427%
Bank & private debt17%
Other / undisclosed320%
Coming soon